Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Verna

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Digestive Diseases and Sciences|November 4, 2017
Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with CirrhosisGiuseppe Cullaro, Grace Kim, Marcus R Pereira, et al.
Transplantation|January 5, 2018
Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver TransplantationGiuseppe Cullaro, Joseph F Pisa, Robert S Brown, et al.
Gastroenterology & Hepatology|April 9, 2014
Immunoglobulin g4-associated cholangitis can mimic cholangiocarcinoma on radiologic and cholangioscopic findingsSusana Gonzalez, Roger Klein Moreira, Elizabeth C Verna, et al.
Journal of Hepatology|July 20, 2020
Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant"Elizabeth C Verna, Lucy Akushevich, Monika Vainorius, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Utilization of Hepatitis C Virus (HCV)-Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence?Elizabeth C Verna, Demetra Tsapepas, Jean C Emond, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 2025
The impact of frailty on liver transplant candidacy - A survey study on current clinical practices in the United StatesAvesh J Thuluvath, Adam Buckholz, Arpan Patel, et al.
Journal of Hepatology|May 19, 2023
Evaluation of recipients with significant comorbidity - Patients with cardiovascular diseaseEmmanuel A Tsochatzis, Kymberly D Watt, Lisa B VanWagner, et al.
The American Journal of Surgical Pathology|October 13, 2012
The Hepatitis Aggressiveness Score (HAS): a novel classification system for post-liver transplantation recurrent hepatitis CRoger K Moreira, Marcela Salomao, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 23, 2024
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosisGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Research Square|May 20, 2024
Applying Metabolomics and Aptamer-based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney InjuryGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Digestive Diseases and Sciences|November 4, 2017
Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with CirrhosisGiuseppe Cullaro, Grace Kim, Marcus R Pereira, et al.
Transplantation|January 5, 2018
Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver TransplantationGiuseppe Cullaro, Joseph F Pisa, Robert S Brown, et al.
Gastroenterology & Hepatology|April 9, 2014
Immunoglobulin g4-associated cholangitis can mimic cholangiocarcinoma on radiologic and cholangioscopic findingsSusana Gonzalez, Roger Klein Moreira, Elizabeth C Verna, et al.
Journal of Hepatology|July 20, 2020
Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant"Elizabeth C Verna, Lucy Akushevich, Monika Vainorius, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Utilization of Hepatitis C Virus (HCV)-Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence?Elizabeth C Verna, Demetra Tsapepas, Jean C Emond, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 2025
The impact of frailty on liver transplant candidacy - A survey study on current clinical practices in the United StatesAvesh J Thuluvath, Adam Buckholz, Arpan Patel, et al.
Journal of Hepatology|May 19, 2023
Evaluation of recipients with significant comorbidity - Patients with cardiovascular diseaseEmmanuel A Tsochatzis, Kymberly D Watt, Lisa B VanWagner, et al.
The American Journal of Surgical Pathology|October 13, 2012
The Hepatitis Aggressiveness Score (HAS): a novel classification system for post-liver transplantation recurrent hepatitis CRoger K Moreira, Marcela Salomao, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 23, 2024
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosisGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Research Square|May 20, 2024
Applying Metabolomics and Aptamer-based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney InjuryGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Pageof 23